1 H NMR spectrum (400 MHz, 297 K, CDCl3) of compound 3 Figure S4 13 C{ 1 H} NMR spectrum (100 MHz, 297 K, CDCl3) of compound 3 Figure S5 1 H NMR spectrum (400 MHz, 297 K, CDCl3) of compound 4a Figure S6 13 C{ 1 H} NMR spectrum (100 MHz, 297 K, CDCl3) of compound 4a Figure S7 1 H NMR spectrum (400 MHz, 297 K, CDCl3) of compound 4a Figure S8 13 C{ 1 H} NMR spectrum (100 MHz, 297 K, CDCl3) of compound 4a Figure S9 1 H NMR spectrum (400 MHz, 297 K, CDCl3) of compound 4b Figure S10 13 C{ 1 H} NMR spectrum (100 MHz, 297 K, CDCl3) of compound 4b HPLC condition: Chiralcel OD-H column, 1.0 mL/min, 5% i-PrOH/Hexane, 210 nm, tminor = 6.66 min, tmajor = 6.00 min.
Racemic 3a
(3R,5S)-tert-butyl 3-benzyl-5-hydroxyisoxazolidine-2-carboxylate (3a) with 92% ee HPLC condition: Chiralcel AD-H column, 1.0 mL/min, 5% i-PrOH/Hexane, 210 nm, tminor = 11.02 min, tmajor = 9.30 min.
Racemic 3j
(3R,5S)-tert-butyl 5-hydroxy-3-(2,4,5-trifluorobenzyl)isoxazolidine-2-carboxylate (3j) with 96% ee HPLC condition: Chiralcel AD-H column, 1.0 mL/min, 5% i-PrOH/Hexane, 210 nm, tminor = 10.02 min, tmajor = 8.08 min.
Racemic 4 (3R)-tert-butyl 3-benzyl-5-(tert-butoxycarbonyloxy)isoxazolidine-2-carboxylate (4) with 43% ee
